Harjeet Singh

5.1k citations

57 papers · 3.4k indexed · 1 hit paper · h-index 29

Co-authors: Laurence J.N. Cooper Richard E. Champlin Helen Huls Simon Olivares Dean A. Lee Partow Kebriaei Sourindra N. Maiti Tiejuan Mi
Topics: CAR-T cell therapy research (48 papers)Virus-based gene therapy research (11 papers)Immune Cell Function and Interaction (9 papers)
Cited by: Oncology Immunology Genetics
Journals: Proceedings of the National Academy of Sciences Circulation Journal of Clinical Investigation
Partner nations: United States Germany Switzerland

In The Last Decade

Harjeet Singh

51 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

2012 489 citations Cecele J. Denman, V. V. Senyukov et al. PLoS ONE profile →

Peers

Countries citing papers authored by Harjeet Singh

Since Specialization

Citations

This map shows the geographic impact of Harjeet Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harjeet Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harjeet Singh more than expected).

Fields of papers citing papers by Harjeet Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harjeet Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harjeet Singh. The network helps show where Harjeet Singh may publish in the future.

Co-authorship network of co-authors of Harjeet Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Harjeet Singh. A scholar is included among the top collaborators of Harjeet Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harjeet Singh. Harjeet Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses 2022 ·Journal of Clinical Investigation ·Gabrielle Romain,Paolo Strati,Ali Rezvan,Mohsen Fathi,Irfan Bandey,(unknown),Darren Heeke,Ivan Liadi,Mario L. Marques‐Piubelli,Luisa M. Solis,Ankit Mahendra,Francisco Vega,Laurence J.N. Cooper,Harjeet Singh,Mike Mattie,Adrian Bot,Sattva S. Neelapu,Navin Varadarajan	36
2	Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia 2021 ·Leukemia ·Francesco Paolo Tambaro,Harjeet Singh,(unknown),Michael Rytting,Kris M. Mahadeo,Philip A. Thompson,Naval Daver,Courtney D. DiNardo,Tapan M. Kadia,Guillermo Garcia‐Manero,Tim Hon Man Chan,Rutul R. Shah,William G. Wierda	123
3	Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors? 2020 ·Biology of Blood and Marrow Transplantation ·Uri Greenbaum,Fevzi Yalniz,Samer A. Srour,Katayoun Rezvani,Harjeet Singh,Amanda Olson,George R. Blumenschein,David S. Hong,Elizabeth J. Shpall,Partow Kebriaei	7
4	Gene Therapy with the Sleeping Beauty Transposon System 2017 ·Trends in Genetics ·Partow Kebriaei,Zsuzsanna Izsvák,(unknown),Harjeet Singh,Zoltán Ivics	89
5	Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells 2016 ·Proceedings of the National Academy of Sciences ·Lenka V. Hurton,Harjeet Singh,Amer Najjar,Kirsten C. Switzer,Tiejuan Mi,Sourindra N. Maiti,Simon Olivares,Brian Rabinovich,Helen Huls,Marie-Andrée Forget,(unknown),Partow Kebriaei,Dean A. Lee,Richard E. Champlin,Laurence J.N. Cooper	341
6	Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors 2016 ·PLoS ONE ·Radhika Thokala,Simon Olivares,Tiejuan Mi,Sourindra N. Maiti,Drew C. Deniger,Helen Huls,Hiroki Torikai,Harjeet Singh,Richard E. Champlin,Tamara Laskowski,George McNamara,Laurence J.N. Cooper	51
7	Very Rapid Production of CAR+ T-Cells upon Non-Viral Gene Transfer Using the Sleeping Beauty System 2016 ·Blood ·Lenka V. Hurton,Harjeet Singh,Kirsten C. Switzer,Tiejuan Mi,Leo G. Flores,Aaron Orozco,Sourindra N. Maiti,Shihuang Su,Amer Najjar,M. Helen Huls,Partow Kebriaei,Richard E. Champlin,Laurence J.N. Cooper	1
8	Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells 2015 ·Cancer Immunology Research ·Ivan Liadi,Harjeet Singh,Gabrielle Romain,Nicolas Rey-Villamizar,(unknown),(unknown),Partow Kebriaei,Helen Huls,Peng Qiu,Badrinath Roysam,Laurence J.N. Cooper,Navin Varadarajan	76
9	Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma 2015 ·Clinical Cancer Research ·Janani Krishnamurthy,Brian Rabinovich,Tiejuan Mi,Kirsten C. Switzer,Simon Olivares,Sourindra N. Maiti,Joshua B. Plummer,Harjeet Singh,Pappanaicken R. Kumaresan,Helen Huls,Feng Wang‐Johanning,Laurence J.N. Cooper	89
10	Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity 2015 ·Cancer Research ·Hillary G. Caruso,Lenka V. Hurton,Amer Najjar,David Rushworth,Sonny Ang,Simon Olivares,Tiejuan Mi,Kirsten C. Switzer,Harjeet Singh,Helen Huls,Dean A. Lee,Amy B. Heimberger,Richard E. Champlin,Laurence J.N. Cooper	324
11	Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations 2015 ·PLoS ONE ·Drew C. Deniger,Jianqiang Yu,M. Helen Huls,Matthew J. Figliola,Tiejuan Mi,Sourindra N. Maiti,George F. Widhopf,Lenka V. Hurton,Radhika Thokala,Harjeet Singh,Simon Olivares,Richard E. Champlin,William G. Wierda,Thomas J. Kipps,Laurence J.N. Cooper	44
12	Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor 2015 ·Cancer Gene Therapy ·Harjeet Singh,Judy S. Moyes,M. Helen Huls,Laurence J.N. Cooper	63
13	Sleeping Beauty System to Redirect T-cell Specificity for Human Applications 2013 ·Journal of Immunotherapy ·Sourindra N. Maiti,Helen Huls,Harjeet Singh,Margaret J. Dawson,Matthew J. Figliola,Simon Olivares,(unknown),(unknown),Asha S. Multani,Ge Yang,Ling Zhang,(unknown),Sonny Ang,Hiroki Torikai,Brian Rabinovich,Dean A. Lee,Partow Kebriaei,Perry B. Hackett,Richard E. Champlin,Laurence J.N. Cooper	67
14	Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor 2013 ·Molecular Therapy ·(unknown),Kirsten C. Switzer,Tiejuan Mi,Sourindra Maiti,Lenka V. Hurton,Harjeet Singh,Helen Huls,Simon Olivares,Dean A. Lee,Richard E. Champlin,Laurence J.N. Cooper	150
15	Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood 2013 ·Journal of Visualized Experiments ·M. Helen Huls,Matthew J. Figliola,Margaret J. Dawson,Simon Olivares,Partow Kebriaei,Elizabeth J. Shpall,Richard E. Champlin,Harjeet Singh,Laurence J.N. Cooper	43
16	Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells 2013 ·PLoS ONE ·Harjeet Singh,Matthew J. Figliola,Margaret J. Dawson,Simon Olivares,Ling Zhang,Ge Yang,Sourindra Maiti,Pallavi R. Manuri,Vladimir Senyukov,Bipulendu Jena,Partow Kebriaei,Richard E. Champlin,Helen Huls,Laurence J.N. Cooper	130
17	Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cellsbreakdown → 2012 ·PLoS ONE ·Cecele J. Denman,V. V. Senyukov,Srinivas S. Somanchi,Prasad V. Phatarpekar,Lisa M. Kopp,Jennifer L. Johnson,Harjeet Singh,Lenka V. Hurton,Sourindra N. Maiti,M. Helen Huls,Richard E. Champlin,Laurence J.N. Cooper,Dean A. Lee	489
18	Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies 2011 ·Cancer Research ·Harjeet Singh,Matthew J. Figliola,Margaret J. Dawson,Helen Huls,Simon Olivares,Kirsten C. Switzer,Tiejuan Mi,Sourindra N. Maiti,Partow Kebriaei,Dean A. Lee,Richard E. Champlin,Laurence J.N. Cooper	161
19	The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor 2011 ·Gene Therapy ·(unknown),Sourindra N. Maiti,Helen Huls,Harjeet Singh,Simon Olivares,Lajos Mátés,Zsuzsanna Izsvák,Zoltán Ivics,Dean A. Lee,Richard E. Champlin,Laurence J.N. Cooper	89
20	Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy 2007 ·Cancer Research ·Harjeet Singh,Lisa Marie Serrano,(unknown),Simon Olivares,George McNamara,David Smith,Zaid Al‐Kadhimi,Stephen J. Forman,Stephen D. Gillies,Michael C. Jensen,David Colcher,Andrew Raubitschek,Laurence J.N. Cooper	31

About Harjeet Singh

Harjeet Singh is a scholar working on Oncology, Immunology and Genetics, having authored 57 papers that have together received 3.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (48 papers), Virus-based gene therapy research (11 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (1.4k citations) and Genetics (988 citations). Harjeet Singh has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Laurence J.N. Cooper, Richard E. Champlin, Helen Huls, Simon Olivares, Dean A. Lee, Partow Kebriaei, Sourindra N. Maiti, Tiejuan Mi, Lenka V. Hurton and Kirsten C. Switzer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact